COMP <GO>
CHE vs OPCH // OPERATING MARGIN
Chemed Corp (NYSE) VS. Option Care Health Inc. (NASDAQ) • 15-METRIC TALLY: CHE 8
— OPCH 4
▲ OPERATING MARGIN LEADER: CHE
LAST: $534.72 (-1.33%) • MKT CAP: $6.96B
operating-margins
13.40%
LAST: $31.83 (-0.06%) • MKT CAP: $4.77B
operating-margins
6.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHE VS. OPCH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHE | OPCH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.50% | 19.30% | +13.20 | CHE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 23.40% | 11.90% | +11.50 | CHE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.5x | 15.3x | +3.20 | OPCH | /valuation <GO> |
| Free Cash Flow Yield | 4.60% | 4.55% | +0.05 | CHE | /fcf-yield <GO> |
| Operating Margin ACTIVE | 13.40% | 6.00% | +7.40 | CHE | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 3.70% | -3.70 | OPCH | /net-margins <GO> |
| Revenue Growth (YoY) | 65.30% | 13.00% | +52.30 | CHE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.45% | 0.00% | +0.45 | CHE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.68 | 3.81 | +8.87 | CHE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.3 | 83.8 | -24.50 | OPCH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 1.10 | -0.02 | OPCH | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 19.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.96B | $4.77B | $2.19B | CHE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHE REV | OPCH REV | CHE GROSS % | OPCH GROSS % | CHE FCF | OPCH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | $5.65B | 32.5% | 19.3% | $325.5M | $217.1M |
| FY 2024 | $1.53B | $5.00B | — | 20.3% | $368.0M | $287.8M |
| FY 2023 | $1.32B | $4.30B | — | — | $271.1M | $177.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHE // BETA 1.08
OPCH // BETA 1.10